Igor Matushansky's most recent trade in Immuneering Corp - Ordinary Shares Class A was a trade of 118,000 Stock Option done . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immuneering Corp - Ordinar... | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 118,000 | 118,000 | - | - | Stock Option | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 92,950 | 92,950 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2022 | 92,950 | 92,950 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 24,888 | 24,888 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 01 Feb 2022 | 14,933 | 100,240 (0%) | 0% | 3 | 44,799 | Common Stock |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2021 | 95,250 | 95,250 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 31,656 | 8,079 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. | 16 Dec 2020 | 29,628 | 93,881 (0%) | 0% | 0.1 | 2,963 | Common Stock |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. | 16 Dec 2020 | 19,360 | 75,754 (0%) | 0% | 0.1 | 1,936 | Common Stock |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.76 per share. | 16 Dec 2020 | 16,478 | 77,403 (0%) | 0% | 11.8 | 193,781 | Common Stock |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.70 per share. | 16 Dec 2020 | 11,501 | 64,253 (0%) | 0% | 11.7 | 134,562 | Common Stock |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 11,367 | 14,208 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 5,965 | 7,669 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. | 16 Dec 2020 | 640 | 56,774 (0%) | 0% | 0.1 | 64 | Common Stock |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 640 | 39,735 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.70 per share. | 16 Dec 2020 | 380 | 56,394 (0%) | 0% | 11.7 | 4,446 | Common Stock |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2020 | 2,736 | 56,134 (0%) | 0% | 0 | Common Stock |